esketamine
Commercial- Indications
- Treatment-resistant depression
Company intelligence / Profile preview
Provides outpatient psychiatric care including medication management, counseling/psychotherapy, Transcranial Magnetic Stimulation with BrainsWay Deep TMS system for depression and OCD; offers ketamine and Spravato/esketamine for treatment-resistant depression; provides Medication Assisted Treatment with Suboxone for opioid addiction; group therapy and intensive outpatient programs available. No proprietary drug development or clinical trial pipeline. Clinical results are consistent with established efficacy of these interventions.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solace Behavioral Health.